April 27, 2021 11:41 AM EDTUpdated April 29, 02:24 PM
News Briefing

News brief­ing: Af­ter lengthy odyssey, Rea­ta is fi­nal­ly ready for its close­up; MIT's Hock­field takes board seat at Reper­toire

John Carroll

Editor & Founder

Josh Sullivan

Close to 10 years af­ter its once-promis­ing pro­gram for bar­dox­olone in chron­ic kid­ney dis­ease im­plod­ed on safe­ty fears, Rea­ta is now prep­ping for its first …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: CEO of Unit­ed­Health in­sur­ance unit shot and killed in New York in what po­lice call ‘a brazen, tar­get­ed ...

Blue­bird and Ver­tex's sick­le cell gene ther­a­pies to kick off new Med­ic­aid ac­cess mod­el

Lil­ly beats No­vo in bell­wether head-to-head weight loss study

As 23andMe strug­gles, an­oth­er ge­net­ic test­ing com­pa­ny bets on drug dis­cov­ery

Mod­er­na CEO de­fends pan­dem­ic prep ef­forts with crit­ics set to en­ter Trump’s ad­min­is­tra­tion

Trade group tells FDA that semaglu­tide is not too 'com­plex' for com­pound­ing

A service from the Financial Times